Your cart is empty.
Zurich, Switzerland, December 19th 2006 – Tecan today announced that the Board of Directors of the Tecan Group AG has appointed Matthew Robin and Carl Severinghaus as members of the Group Executive Committee. With the further strengthening of the senior management team and the new organizational structure implemented earlier this year, Tecan continues to expand its capabilities for the targeted execution in its key markets.
Matthew Robin will assume his new position on February 1st 2007. He will be responsible for managing the company’s Liquid Handling and Robotics business unit. Currently, this role is filled on an interim basis by Thomas Bachmann, CEO of Tecan. From 2003 until September 2006, Matthew Robin was CEO of the medical technology company Ypsomed. Previously, he held various senior management positions in the Disetronic Group which was a predecessor of Ypsomed.
Following his degree in chemical engineering from Imperial College in London, he began his professional career at Lonza where he held multiple functions in the US and Switzerland. Matthew Robin is 41 years old and British citizen.
Effective January 1st 2007, Carl Severinghaus will assume the worldwide management of the newly created Direct Sales organization.
Carl Severinghaus has more than 15 years of experience with Tecan, having joined the company in 1991. During this time, he has held multiple senior management positions and for the past 10 years has been responsible for managing Tecan’s single largest sales organization, Tecan US. Carl Severinghaus has an extensive track-record in the life-sciences and diagnostics industries, having held positions not only with Tecan, but also with Beckman Coulter and American Monitor Corporation. He is 54 years of age and an American citizen.
Tecan (www.tecan.com) is a leading player in the life sciences supply industry. The company specializes in the development, production and distribution of automation solutions which facilitate the researching of active pharmaceutical compounds, as well as diagnostics, pharmaceutical research and forensics for clients in the life sciences sector. Through its REMP subsidiary (www.remp.com), Tecan is the leading supplier of large-scale automated storage and retrieval systems. Tecan clients are pharmaceutical and biotechnology companies, university research departments and diagnostic laboratories. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2005, Tecan achieved sales of CHF 344.9 million (USD 275.9 million; EUR 222.5 million). Registered shares of Tecan Group are traded on the SWX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Valor: 1210019).
Chief Financial Officer
Senior Vice President
Business Development &